Searched for
AVRA LABORATORIES.
Pharma raw material makers in race to tank up on CXO talentSome of these PE-owned platform companies include Advent International-led Cohance Lifesciences / Suven Pharma, PAG and CX Partners-funded ...- ADIA, HarbourVest eye minor stake in CohanceADIA and HarbourVest are in discussions to acquire a minority stake in Cohance Lifesciences, a pharmaceuticals platform owned by Advent Int...
- Advent International buys Suven Pharma for Rs 6,313 croreAdvent will also launch an open offer for an additional 26% of the company, a listed contract research and manufacturing services (CRAMS) b...
- Suven Pharma falls 2% as Advent picks majority stake in the companyPost the completion of this acquisition, Advent intends to explore the merger of its portfolio company, Cohance Lifesciences with Suven, to...
- Advent pips Blackstone, set to buy Suven Pharma for Rs 6300 crMarket capitalisation of Suven Pharma, as on Friday, was ₹12,682.43 crore. ET was the first to report on the sale on December 23. Advent is...
- Advent pips Blackstone, set to buy Suven Pharma for Rs 6300 crAnnouncement expected as early as Monday morning. Open offer if fully subscribed to could make it a $1 bn deal
- Advent closes in on Suven Pharma buyoutPromoters Venkateswarlu Jasti and his family split Suven Life Sciences in FY20, turning the CRAMS business into a separately listed company...
- PE firm Advent names its India API, CDMO platform as Cohance LifesciencesThe US-based PE firm which is betting on India pharma, said that it intends to add more assets in the future with the vision to become one ...
- Advent buys controlling stake in Avra Labs for $100 millionThe transaction is Advent’s fifth investment in India over the past 12 months
- When ace scientists like Rajesh Gokhale turn rookie entrepreneursScientists of distinction are setting up companies but with a difference — to help solve difficult problems of business and society.
Load More
